Very recently, MCAM was also shown to regulate the stemness and chemoresistance of hepatocellular carcinoma through the activation of NFκB, resulting in an increased level of JAG2 and activation of the NOTCH pathway [31]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.